Monday 13 November 2017

Have commercial imperatives won when it comes to biomedical research? Professor Jenny Reardon argues that genomics hasn’t delivered on promised public and civic values. Simplistic narratives of cures and miracle drugs obscure harder questions about the meaning of and control over genomic data. While not denying the scientific break-throughs of genomics, she fears justice is falling by the wayside.

[ Read More ]